Hedgehog Treatment of Down Syndrome: Establishing Mechanisms
唐氏综合症的刺猬疗法:建立机制
基本信息
- 批准号:8931797
- 负责人:
- 金额:$ 19.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-22 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenal hormone preparationAdultAdverse effectsAffectAgeAge-MonthsAgonistAnatomyAntibioticsAreaAttenuatedBehaviorBiological AssayBirthBrainBrain PartBrain regionCell CountCell ProliferationCellsCerebellumChildChildhood Malignant Brain TumorChromosomes, Human, Pair 21ClinicCognitiveComplementary DNACongenital cerebellar hypoplasiaCountryCytoplasmic GranulesDNADataDevelopmentDoseDown SyndromeDown-RegulationDoxycyclineDrug Delivery SystemsEmbryonic DevelopmentEmotionalEpidemiologyErinaceidaeEvaluationExposure toFamilyGene ExpressionGenesGeneticGrowth FactorHippocampus (Brain)HumanHuman Cell LineHuman ChromosomesInjection of therapeutic agentIntellectual functioning disabilityJournalsLaboratoriesLearningLifeLightLinkLuciferasesMalignant NeoplasmsMapsMediatingMedicalMemoryMethodsMitoticMorphologyMothersMotionMusMutationNeonatalNeural Crest CellNeuronsOncogenicOrthologous GenePerformancePersonsPharmacologyPhysiologyPlayPopulationProblem SolvingProcessProductionProsencephalonPurkinje CellsRecoveryResistanceRoleSeriesSignal TransductionSiteSocietiesSonic Hedgehog PathwayStructural defectStructureSynaptic plasticitySyndromeSystemTestingTetanus Helper PeptideTherapeuticThyroid HormonesTimeTranslatingTrisomyValidationWaterbiological systemscDNA Librarycell transformationcombinatorialcostdentate gyrusdisabilityexpression cloninggene functiongenetic approachgranule cellhuman SMO proteinimprovedin vivomedulloblastomamouse Ts65Dnmouse modelneonateneuro-oncologyoverexpressionpostnatalprogramspromoterpublic health relevancepupresearch studyresponserestraintscreeningsmall moleculesmoothened signaling pathwayyoung adult
项目摘要
DESCRIPTION (provided by applicant): Down syndrome (DS), caused by trisomy for human chromosome 21 (Hsa21), is the most common genetically defined cause of intellectual disability. Structural abnormalities that are thought to contribute to learning problems are seen in the cerebellum and hippocampus of people with the condition. Treatments to correct these parts of the brain would tangibly improve the lives of children and young adults with DS and would allow them to better integrate into society. We recently showed that a single injection on the day of birth with the Sonic Hedgehog (Shh) agonist, SAG 1.1, permanently normalizes the size and gross anatomy of the cerebellum, leads to better adult spatial problem solving, and restores electrophysiological correlates of learning in the CA1-hippocampal subfield of the Ts65Dn mouse model of DS. A number of questions remain before this finding can be translated to therapy for people. Whether improvements in hippocampal behavior & physiology occur through Shh-induced normalization of cerebellar structure or via direct stimulation with Shh is not known. Another restraint on advancing Shh treatments to the clinic is the very wide range of effects of this potent growth factor, making systemic application in people problematic. A more confined method of drug delivery might limit side effects. Another approach would be to understand which Hsa21 genes act to downregulate the Shh pathway response in cerebellum, which might suggest more "druggable" targets. The experiments proposed here will first screen Shh responses with an Hsa21 Gene Expression clone-set of 169 cDNAs, 149 of which are highly conserved between human and mouse and twenty that are human specific. Genes that significantly decrease Shh pathway activation in the LIGHT2 assay will be evaluated in additional Shh-sensitive assays to assure that they generalize across different biological systems (Specific Aim 1). Next, we will determine how region-specific expression of Shh in the Ts65Dn brain affects hippocampal function. Using a conditional "temporal-spatial" genetics approach that will allow us to increase Shh expression at birth for a 24h period selectively within
the Purkinje cells of the cerebellum, or within the hippocampus, we will determine whether cerebellar Shh expression is necessary and/or sufficient to correct the behavior & physiology of adult Ts65Dn mice in hippocampal tests or whether Shh actions in additional parts of the brain are required (Specific Aim 2).
描述(由申请人提供):唐氏综合征(DS),由人类21号染色体三体(Hsa 21)引起,是智力残疾最常见的遗传原因。被认为是导致学习问题的结构异常出现在患有这种疾病的人的小脑和海马体中。纠正这些大脑部位的治疗将切实改善患有DS的儿童和年轻人的生活,并使他们更好地融入社会。我们最近发现,出生当天单次注射Sonic Hedgehog(Shh)激动剂SAG 1.1,永久正常化小脑的大小和大体解剖结构,导致更好的成人空间问题解决,并恢复DS Ts 65 Dn小鼠模型CA 1-海马子区学习的电生理相关性。在这一发现转化为治疗方法之前,还有许多问题有待解决。尚不清楚海马行为和生理学的改善是通过Shh诱导的小脑结构正常化还是通过Shh的直接刺激来实现的。将Shh治疗推进到临床的另一个限制是这种强效生长因子的影响范围非常广泛,这使得人们的系统应用成为问题。一种更严格的药物输送方法可能会限制副作用。另一种方法是了解哪些Hsa 21基因在小脑中下调Shh通路反应,这可能表明更多的“药物”靶点。本文提出的实验将首先用169个cDNA的Hsa 21基因表达克隆集筛选Shh应答,其中149个在人和小鼠之间高度保守,20个是人类特异性的。在LIGHT 2试验中显著降低Shh通路活化的基因将在额外的Shh敏感试验中进行评价,以确保它们在不同的生物系统中具有普遍性(特定目的1)。接下来,我们将确定Ts 65 Dn脑中Shh的区域特异性表达如何影响海马功能。使用有条件的“时空”遗传学方法,这将使我们能够在出生时选择性地增加Shh表达24小时,
小脑的浦肯野细胞或海马内的浦肯野细胞,我们将确定小脑Shh表达是否是必要的和/或足以在海马测试中校正成年Ts 65 Dn小鼠的行为和生理学,或者是否需要在大脑的其他部分中的Shh作用(具体目标2)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger H Reeves其他文献
Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression
- DOI:
10.1186/1476-4598-4-28 - 发表时间:
2005-08-05 - 期刊:
- 影响因子:33.900
- 作者:
Thomas E Sussan;Mathew T Pletcher;Yoshinori Murakami;Roger H Reeves - 通讯作者:
Roger H Reeves
Roger H Reeves的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger H Reeves', 18)}}的其他基金
Chromosome 21 Elimination In A New Mouse Model of Down Syndrome
新唐氏综合症小鼠模型中 21 号染色体的消除
- 批准号:
9926296 - 财政年份:2019
- 资助金额:
$ 19.74万 - 项目类别:
Hedgehog Treatment of Down Syndrome: Establishing Mechanisms
唐氏综合症的刺猬疗法:建立机制
- 批准号:
8808144 - 财政年份:2014
- 资助金额:
$ 19.74万 - 项目类别:
TEMPORAL ANALYSIS OF IMMUNE RESPONSES AND PROTECTION INDUCED BY SIVDELTANEF
SIVDELTANEF 引起的免疫反应和保护的时间分析
- 批准号:
8357949 - 财政年份:2011
- 资助金额:
$ 19.74万 - 项目类别:
PROTECTION AGAINST VAGINAL CHALLENGE IN SIVDELTANEF-VACCINATED ANIMALS
接种 SIVDELTANEF 疫苗的动物免受阴道感染的保护
- 批准号:
8357958 - 财政年份:2011
- 资助金额:
$ 19.74万 - 项目类别:
PROTECTION AGAINST VAGINAL CHALLENGE IN SIVDELTANEF-VACCINATED ANIMALS
接种 SIVDELTANEF 疫苗的动物免受阴道感染的保护
- 批准号:
8172873 - 财政年份:2010
- 资助金额:
$ 19.74万 - 项目类别:
TEMPORAL ANALYSIS OF IMMUNE RESPONSES AND PROTECTION INDUCED BY SIVDELTANEF
SIVDELTANEF 引起的免疫反应和保护的时间分析
- 批准号:
8172861 - 财政年份:2010
- 资助金额:
$ 19.74万 - 项目类别:
PROTECTION AGAINST VAGINAL CHALLENGE IN SIVDELTANEF-VACCINATED ANIMALS
接种 SIVDELTANEF 疫苗的动物免受阴道感染的保护
- 批准号:
7958387 - 财政年份:2009
- 资助金额:
$ 19.74万 - 项目类别:
TEMPORAL ANALYSIS OF IMMUNE RESPONSES AND PROTECTION INDUCED BY SIVDELTANEF
SIVDELTANEF 引起的免疫反应和保护的时间分析
- 批准号:
7958368 - 财政年份:2009
- 资助金额:
$ 19.74万 - 项目类别:
TEMPORAL ANALYSIS OF IMMUNE RESPONSES AND PROTECTION INDUCED BY SIVDELTANEF
SIVDELTANEF 引起的免疫反应和保护的时间分析
- 批准号:
7715532 - 财政年份:2008
- 资助金额:
$ 19.74万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 19.74万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 19.74万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 19.74万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 19.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 19.74万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 19.74万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)